Researchers found a 60% decrease in moderate and severe depression and 73% decrease in suicidality among transgender and non-binary youth who received puberty blockers or gender-affirming hormones over a 12-month period, according to a study abstract presented during the virtual American Academy of Pediatrics 2021 National Conference & Exhibition.